IT vs NRIX · P/E 16, rev $6.27B vs rev $54.5M
Gartner Inc (IT) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
IT currently screens at market cap $11.03B and trailing P/E 16.3. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the IT and NRIX stock pages for the full models.
Not investment advice.